U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213788
Company: ACCORD HLTHCARE INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BREXPIPRAZOLE BREXPIPRAZOLE 0.25MG TABLET; ORAL None (Tentative Approval) None No No
BREXPIPRAZOLE BREXPIPRAZOLE 0.5MG TABLET; ORAL None (Tentative Approval) None No No
BREXPIPRAZOLE BREXPIPRAZOLE 1MG TABLET; ORAL None (Tentative Approval) None No No
BREXPIPRAZOLE BREXPIPRAZOLE 2MG TABLET; ORAL None (Tentative Approval) None No No
BREXPIPRAZOLE BREXPIPRAZOLE 3MG TABLET; ORAL None (Tentative Approval) None No No
BREXPIPRAZOLE BREXPIPRAZOLE 4MG TABLET; ORAL None (Tentative Approval) None No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/17/2021 ORIG-1 Tentative Approval STANDARD Letter (PDF)

Label is not available on this site.

 https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213788Orig1s000TA_ltr.pdf
Back to Top